Is a Motor Criterion Essential for the Diagnosis of Clinical Huntington Disease?

PLoS Currents

Volumn , Issue APR 2013, 2013, Pages

  Loy, Clement T ^a,b   McCusker, Elizabeth A ^a,c  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BEHAVIOR; CASE REPORT; COGNITION; DEPRESSION; EYE MOVEMENT; GENETIC SCREENING; HALLUCINATION; HUMAN; HUNTINGTON CHOREA; JOB PERFORMANCE; MALE; MENTAL HEALTH; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; PSYCHIATRY; WEIGHT REDUCTION;

EID: 84876316010     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.hd.f4c66bd51e8db11f55e1701af937a419     Document Type: Article

References (9)

1. ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group. Am J Hum Genet. 1998 May;62(5):1243-7. PubMed PMID:9545416. 9545416.
2. Unified Huntington9s Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord. 1996 Mar;11(2):136-42. PubMed PMID:8684382. 8684382.
3. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M. Detection of Huntington9s disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):874-80. PubMed PMID:18096682. 18096682.
4. Biglan KM, Zhang Y, Long J, Geschwind M, Kang G, Killoran A, Lu W, McCusker E, Mills JA, Raymond LA, Testa C, Wojcieszek J and Paulsen JS. Refining the diagnosis of Huntington Disease: The PREDICT-HD study. Front. Aging Neurosci. 2013; 5:12. 10.3389/fnagi.2013.00012.
5. Albin RL, Young AB, Penney JB, Handelin B, Balfour R, Anderson KD, Markel DS, Tourtellotte WW, Reiner A. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington9s disease. N Engl J Med. 1990 May 3;322(18):1293-8. PubMed PMID:1691447. 1691447.
6. Gómez-Tortosa E, MacDonald ME, Friend JC, Taylor SA, Weiler LJ, Cupples LA, Srinidhi J, Gusella JF, Bird ED, Vonsattel JP, Myers RH. Quantitative neuropathological changes in presymptomatic Huntington9s disease. Ann Neurol. 2001 Jan;49(1):29-34. PubMed PMID:11198293. 11198293.
7. Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC. Biological and clinical changes in premanifest and early stage Huntington9s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011 Jan;10(1):31-42. PubMed PMID:21130037. 21130037.
8. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH. Toward defining the preclinical stages of Alzheimer9s disease: recommendations from the National Institute on Aging-Alzheimer9s Association workgroups on diagnostic guidelines for Alzheimer9s disease. Alzheimers Dement. 2011 May;7(3):280-92. PubMed PMID:21514248. 21514248.
9. Berg D. Is pre-motor diagnosis possible? The European experience. Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S195-8. PubMed PMID:22166433. 22166433.